SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-22-007006
Filing Date
2022-10-21
Accepted
2022-10-21 17:01:27
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-1 cns_s1.htm S-1 277173
2 OPINION OF ARENTFOX SCHIFF, LLP cns_ex0501.htm EX-5.1 14157
3 CONSENT OF MALONEBAILEY, LLP cns_ex2301.htm EX-23.1 2612
4 FILING FEE TABLE cns_ex107.htm EX-FILING FEES 23083
5 GRAPHIC image_001.jpg GRAPHIC 6360
  Complete submission text file 0001683168-22-007006.txt   326910
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-267975 | Film No.: 221324299
SIC: 2834 Pharmaceutical Preparations